Fate Therapeutics
FATE
#7514
Rank
C$0.38 B
Marketcap
$3.37
Share price
-5.10%
Change (1 day)
14.45%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$2.94

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.02. In 2022 the company made an earnings per share (EPS) of -$4.05 a decrease over its 2021 EPS that were of -$3.10.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.94-27.47%
2022-$4.0530.49%
2021-$3.107.21%
2020-$2.8945.45%
2019-$1.9919.17%
2018-$1.6717.65%
2017-$1.42-3.77%
2016-$1.47-12.4%
2015-$1.68-3.97%
2014-$1.75-2.09%
2013-$1.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$10.89 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.72-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$12.03 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.31 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.73-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA